Bismarck or Beveridge: a beauty contest between dinosaurs.
BACKGROUND
Health systems delivery systems can be divided into two broad categories: National Health Services (NHS) on the one hand and Social Security (based) Health care systems (SSH) on the other hand. Existing literature is inconclusive about which system performs best. In this paper we would like to improve the evidence-base for discussion about pros and cons of NHS-systems versus SSH-system for health outcomes, expenditure and population satisfaction.


METHODS
In this study we used time series data for 17 European countries, that were characterized as either NHS or SSH country. We used the following performance indicators: For health outcome: overall mortality rate, infant mortality rate and life expectancy at birth. For health care costs: health care expenditure per capita in pppUS$ and health expenditure as percentage of GDP. Time series dated from 1970 until 2003 or 2004, depending on availability. Sources were OECD health data base 2006 and WHO health for all database 2006. For satisfaction we used the Eurobarometer studies from 1996, 1998 and 1999.


RESULTS
SSH systems perform slightly better on overall mortality rates and life expectancy (after 1980). For infant mortality the rates converged between the two types of systems and since 1980 no differences ceased to exist.SSH systems are more expensive and NHS systems have a better cost containment. Inhabitants of countries with SSH-systems are on average substantially more satisfied than those in NHS countries.


CONCLUSIONS
We concluded that the question 'which type of system performs best' can be answered empirically as far as health outcomes, health care expenditures and patient satisfaction are concerned. Whether this selection of indicators covers all or even most relevant aspects of health system comparison remains to be seen. Perhaps further and more conclusive research into health system related differences in, for instance, equity should be completed before the leading question of this paper can be answered. We do think, however, that this study can form a base for a policy debate on the pros and cons of the existing health care systems in Europe.
van der Zee
Jouke
J
NIVEL (Netherlands Institute of Health Services Research), Utrecht, The Netherlands. j.vanderzee@nivel.nl <j.vanderzee@nivel.nl>
Kroneman
Madelon W
MW
D005060:Europe / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data* / Q000639:trends; D005102:Health Expenditures / Q000706:statistics & numerical data* / Q000639:trends; D006302:Health Services Research; D006801:Humans; D008017:Life Expectancy; D017146:Models, Organizational; D009026:Mortality; D009313:National Health Programs / Q000191:economics / Q000458:organization & administration* / Q000592:standards; D017063:Outcome Assessment, Health Care; D015397:Program Evaluation; D019984:Quality Indicators, Health Care; D011787:Quality of Health Care; D012943:Social Security / Q000191:economics / Q000458:organization & administration* / Q000592:standards